Difficulty: Medium
Average Score: 82%
Practice
A 42-year-old woman requires treatment for diabetes insipidus following surgical removal of part of her pituitary gland. The advantage of treating this patient with desmopressin instead of vasopressin is that desmopressin
Correct answer
D
Rationale
Desmopressin, a synthetic analog of vasopressin, is preferred over vasopressin for treating diabetes insipidus due to its higher selectivity for the V2 receptor subtype. This selectivity leads to a more specific action on the renal tubules, resulting in increased water reabsorption without significant vasoconstrictive effects mediated by V1 receptors. This specificity reduces the risk of side effects like hypertension and coronary vasoconstriction associated with vasopressin use.
In contrast, option A (Causes less formation of factor VIII) is incorrect because desmopressin's action on V2 receptors in the kidneys is unrelated to factor VIII production. Option B (Causes less hypernatremia) is incorrect as both desmopressin and vasopressin can lead to hyponatremia due to water retention. Option C (Causes less hyperprolactinemia) is also incorrect as neither desmopressin nor vasopressin affects prolactin levels significantly.
In an educational context, understanding the pharmacological differences between desmopressin and vasopressin is crucial for healthcare providers managing patients with diabetes insipidus. Knowing the specific receptor selectivity of desmopressin can help in making informed treatment decisions and minimizing adverse effects. This knowledge enhances patient care and safety in clinical practice.
In contrast, option A (Causes less formation of factor VIII) is incorrect because desmopressin's action on V2 receptors in the kidneys is unrelated to factor VIII production. Option B (Causes less hypernatremia) is incorrect as both desmopressin and vasopressin can lead to hyponatremia due to water retention. Option C (Causes less hyperprolactinemia) is also incorrect as neither desmopressin nor vasopressin affects prolactin levels significantly.
In an educational context, understanding the pharmacological differences between desmopressin and vasopressin is crucial for healthcare providers managing patients with diabetes insipidus. Knowing the specific receptor selectivity of desmopressin can help in making informed treatment decisions and minimizing adverse effects. This knowledge enhances patient care and safety in clinical practice.